| 11078186 |
ROR γ modulators |
Jingwu Duan, Bin Jiang, T. G. Murali Dhar, Arun Kumar Gupta, Ananta Karmakar |
2021-08-03 |
|
| 10865191 |
Heterocyclic compounds useful as modulators of TNF alpha |
Hai-Yun Xiao, T. G. Murali Dhar, Ning Li, Jingwu Duan, Bin Jiang +3 more |
2020-12-15 |
|
| 10308652 |
Tricyclic heterocyclic compounds useful as inhibitors of TNF |
Stephen T. Wrobleski, Gregory D. Brown, Shuqun Lin, Jingwu Duan, Murali T. G. Dhar +2 more |
2019-06-04 |
|
| 9771320 |
Carbocyclic sulfone RORγ modulators |
Jingwu Duan, T. G. Murali Dhar, Bin Jiang, Ananta Karmakar, Arun Kumar Gupta +1 more |
2017-09-26 |
|
| 9725443 |
RORγ modulators |
T. G. Murali Dhar, Jingwu Duan, Hua Gong, Bin Jiang, David S. Weinstein |
2017-08-08 |
|
| 9708253 |
Cyclohexyl sulfone RORγ modulators |
Jingwu Duan, T. G. Murali Dhar, Bin Jiang, Ananta Karmakar, Arun Kumar Gupta +1 more |
2017-07-18 |
|
| 9663469 |
RORγ modulators |
T. G. Murali Dhar, Jingwu Duan, Hua Gong, Bin Jiang, David S. Weinstein |
2017-05-30 |
|
| 9637455 |
Heterocyclic sulfone RORγ modulators |
Jingwu Duan, T. G. Murali Dhar, Bin Jiang, Ananta Karmakar, Arun Kumar Gupta |
2017-05-02 |
|
| 9458171 |
Pyrrolidinyl sulfone RORγ modulators |
Jingwu Duan, T. G. Murali Dhar, Bin Jiang, Hai-Yun Xiao |
2016-10-04 |
|
| 8987268 |
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
Stephen T. Wrobleski, Jagabandhu Das, Jingwu Duan, Junqing Guo, John Hynes +7 more |
2015-03-24 |
$102,355,000 |
| 8921368 |
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
Stephen T. Wrobleski, Gregory D. Brown, Lidia M. Doweyko, Jingwu Duan, Junqing Guo +8 more |
2014-12-30 |
$242,906,000 |
| 8846673 |
Azaindazoles as kinase inhibitors and use thereof |
Jingwu Duan, Bin Jiang |
2014-09-30 |
$97,713,000 |
| 7888381 |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof |
Jingwu Duan, David S. Weinstein, Bin Jiang |
2011-02-15 |
$49,612,000 |
| 7595317 |
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases |
Jingwu Duan, Bin Jiang, Lihua Chen, Joseph Barbosa, William J. Pitts |
2009-09-29 |
$386,563,000 |
| 7294624 |
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases |
Jingwu Duan, Bin Jiang, Lihua Chen, Joseph Barbosa, William J. Pitts |
2007-11-13 |
$211,728,000 |
| 6984648 |
Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
Thomas P. Maduskuie, Jr., Matthew E. Voss, Chu-Biao Xue, Jingwu Duan, Gregory R. Ott +2 more |
2006-01-10 |
$47,832,000 |
| 6936620 |
Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases |
Jingwu Duan |
2005-08-30 |
$38,939,000 |
| 6743807 |
Cyclic &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr; |
Jingwu Duan, Gregory R. Ott, Lihua Chen, Carl P. Decicco, Thomas P. Maduskuie, Jr. +1 more |
2004-06-01 |
$71,224,000 |
| 6740649 |
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- &agr; converting enzyme (TACE) |
Gregory R. Ott, Xiao-Tao Chen, Jingwu Duan |
2004-05-25 |
$101,956,000 |
